Barrack, Rodos & Bacine Is Investigating PACS Group Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
JPMorgan Resumes PACS Group (PACS) at Overweight
November 6, 2024 6:20 AM ESTJPMorgan analyst Lisa Gill resumes coverage on PACS Group (NYSE: PACS) with a Overweight rating and a price target of $40.00.
The analyst comments "ollowing a period of restriction, we are moving to an OW rating for PACS Group and a December 2025 price target of $40 from a Not Rated designation. Consistent with our previous outlook (see our initiation from earlier this year here), we consider PACS as having an attractive business model focused on acquiring... More
